Journal News

MCP: How exercise works its biomolecular wonders

John Arnst
Dec. 1, 2017

Exercise has long been known to benefit the entire body, from burning fat and strengthening muscles to boosting the immune system and reducing the risk of some cancers. To understand how some of these effects are controlled on a cellular level, researchers at the University of Sydney did a proteomic analysis of the swarm of peptides and small-protein hormones that circulate throughout the body in blood plasma.

Benjamin Parker, the first author on the paper published in Molecular & Cellular Proteomics, said, “There’s a big push in the field to identify secreted factors that allow organs to communicate with each other, and this might enable them to adapt to certain environmental stresses … like exercise.” The researchers ultimately hope that their novel combination of techniques for proteomic analysis might be used to pinpoint the factors behind certain health benefits for potential drug development.

Parker and colleagues used a combination of tagging and fragmentation techniques, multidimensional liquid chromatography and tandem mass spectrometry to identify 5,548 peptides in the peptidome, the aggregate of peptide molecules that circulate in the plasma with blood cells. They found that the levels of the circulating small molecules were modulated rapidly during and after exercise through a network of post-translational modifications and proteases.

“We know that when we exercise, there will be certain factors and hormones that get released into our body, into our bloodstream, that then enable different tissues to adapt to that increased workload,” Parker said. While the researchers noted expected elevated levels of hormones, including insulin and the vasodilator bradykinin, they also found that antimicrobial and immune-related peptides were upregulated.

“We don’t know exactly why the body is doing that, but you could maybe (make the) link that exercise is improving our immune system,” Parker said.

Parker and colleagues analyzed blood samples collected before, during and after exercise from volunteers at a facility at the University of Copenhagen operated by co-authors Erik Richter, Bente Kiens and Jørgen Wojtaszewski, who have been exploring the effects of exercise on various signaling molecules for more than two decades.

The researchers also noted the presence of new, uncharacterized peptides that were found to affect cells’ ability to grow and proliferate, which may play a role in the noted anticancer effects of exercise, Parker said.

Examining the levels of certain peptides in blood plasma also allowed the researchers to characterize the activity of the numerous proteases that cleaved the peptides into their smaller, functional selves. By monitoring these protease levels, Parker and his colleagues were able to infer whether exercise is responsible for an increase or a decrease in specific proteases, some of which have been associated with an increased risk of heart attacks during strenuous exercise for people with higher rates of arterial plaques.

“There’s sort of a controversy in the field about how good it is to activate certain proteases with exercise,” Parker said. “It could be related to how we activate proteases that cause plaques to rupture in our hearts, in our coronary circulation.” In that case, he said, strenuous exercise “may not be always a beneficial thing.”

Parker and colleagues are continuing their proteomic analyses by examining the functional surfaces of exosomes, which are small membrane-bound vesicles used to send proteins, DNA and RNA between distant cells and organs, and they hope to publish their follow-up results soon.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.